Author:
Ilina N I,Nenasheva N M,Avdeev S N,Aisanov Z R,Arkhipov V V,Vizel A A,Emelyanov A V,Knyazheskaya N P,Kurbacheva O M,Leshchenko I V,Osipova G L,Styrt E A,Titova O N,Fassakhov R S,Fedosenko S V
Abstract
The article is based on the resolution of the Expert Council, including experts from Russian Association of Allergists and Clinical Immunologists (RAACI) and Russian Respiratory Society (RRS) dated November 20, 2016, and the review of clinical studies results and publications on the biomarker-based diagnosis and biological treatment of severe uncontrolled asthma. The aim of this work is to develop a phenotype-oriented algorithm of diagnostics and treatment of severe asthma, supported by the biomarker testing for subsequent selection of appropriate immunobiological treatment. The article constitutes the summary of results of clinical studies and expert opinions on the treatment of asthma in patients who do not achieve disease control with standard treatment regimens including high doses of inhaled corticosteroids in the combination with long-acting beta-agonists, tiotropium, and medications from other pharmacological groups according to Russian Respiratory Society (2016) and GINA (2016-2017) guidelines. The article summarizes the results of international randomized clinical studies performed to assess safety and efficacy of new class of biological treatments, monoclonal antibodies acting against major cytokines that are responsible for inflammation, in patients with severe asthma, including a new anti-IL-5 antibody, reslizumab (Cinqaero).
Reference75 articles.
1. Winer R., Qin X., Harrington T., Moorman J., Zahran H. Asthma incidence among children and adults: findings from the Behavioral Risk Factor Surveillance system asthma callback survey-United States, 2006-2008. Journal of Asthma. 2012, v. 49, p. 16-22.
2. Омельяновский В.В. Социально-экономическое бремя бронхиальной астмы и хронической обструктивной болезни легких в Российской Федерации. Отчет по исследованию за 2008-2009 годы. M., 2010, с. 3-82.
3. Chuchalin A.G., Khaltaev N., Аntonov N. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. COPD. 2014, v. 9, p. 963-974.
4. Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика». IV изд. M., 2012, 109 с.
5. Bousqet J., Mantzouranis E., Cruz A.A. et al. Uniform definition of asthma severity, control and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J. Allergy Clin. Immunol. 2010, v. 126, p. 926-938.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献